News — FDA

Opioid Addiction Crisis: Harvard Medical Students Request Better Training
Posted by UTS -

img source: Michael Dykstra   Back in March, The White House asked medical schools to sign a pledge to require students to learn new federal guidelines for safe opioid prescription use. “We are over 10 years into this epidemic, and I don’t think we’ve seen a robust enough response from the medical community,” said Michael Botticelli, head of the White House Office of National Drug Control Policy. Dr. Ted Parran of Case Western Reserve School of Medicine has taught remedial courses for doctors who tend to over-prescribe painkillers. He’s taught this for over 20 years!   Last November, Governor Charlie...

View Article →

Neos Therapeutics: Dissolvable Amphetamine Drug for Kids
Posted by UTS -

img source: neos therapeutics   Recently, the CDC has raised concerns with over-medicating children with ADHD.   Enter Adzenys – a new medication in this ADHD market. This new dissolvable pill aimed directly at children for its ease-of-use and orange-flavoring is concerning doctors and parents due to the fact that the medication is a Schedule 2 Controlled Substance, and the drug’s main selling point of “ease-of-use” may facilitate abuse. With such a widespread use of stimulants being used in today’s society, many in the medical community insist that creating an ODT (orally disintegrating tablet) version of an ADHD drug is a...

View Article →

New Drug Therapy Targeting Chronic Pain
Posted by UTS -

img source: adobeimages With millions of Americans suffering from chronic pain, new treatments and strategies to help lessen pain symptoms are of significant importance. Recently, a study at Northwestern University has combined two FDA-approved drugs, targeting the nucleus accumbens, a brain region responsible for emotions and addiction. One L-dopa drug used for Parkinson’s patients and one non-steroidal anti-inflammatory are administered together in rodents to eliminate chronic pain behavior. This combination raises dopamine levels to more effectively treat chronic pain, the number one cause of disability in the U.S. right now.     

View Article →

FDA Finally Addresses Amphetamine-Like Dietary Supplement
Posted by UTS -

Manufacturers of five dietary supplements were issued warnings about BMPEA, an amphetamine-like substance which can significantly raise heart rate and blood pressure. Pieter Cohen, MD, an assistant professor at Harvard Medical School recently published research which warned the public about this substance, as it was found in 21 supplements. The study was published in the journal Drug Testing and Analysis,stating that, "Physicians should remain vigilant for patients presenting with toxicity from sports and weight-loss supplements as they might contain undisclosed stimulants, such as BMPEA." Supplements containing BMPEA have already been removed from Canadian and European markets. Read more about it...

View Article →